Block & Leviton says it is investigating Immix Biopharma (Nasdaq: IMMX) for potential securities law violations. The notice encourages investors who lost money to contact the firm to explore potential loss recovery, which heightens legal/regulatory overhang for the stock despite no specific financial figures being disclosed.
Block & Leviton says it is investigating Immix Biopharma (Nasdaq: IMMX) for potential securities law violations. The notice encourages investors who lost money to contact the firm to explore potential loss recovery, which heightens legal/regulatory overhang for the stock despite no specific financial figures being disclosed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
